Certified by Founder
Lodge
Ancilia Biosciences
start up
United States
- New York, New York
- 29/08/2024
- Unknown
- $4,200,000
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
- Industry Biotechnology
- Website https://www.anciliabio.com/
- LinkedIn https://www.linkedin.com/company/ancilia/
RenoFi | $22,000,000 | (Mar 4, 2026)
Worldscape | Undisclosed Amount | (Mar 4, 2026)
MightyFly | $10,000,000 | (Mar 4, 2026)
Qura | $1,739,595 | (Mar 4, 2026)
Devotion(US) | $4,000,000 | (Mar 4, 2026)
Burst | $2,100,000 | (Mar 4, 2026)
JetStream Security Inc. | $34,000,000 | (Mar 4, 2026)
Escargot | $2,750,000 | (Mar 4, 2026)
EGI Battery | $10,000,000 | (Mar 4, 2026)
Bindbridge | $3,800,000 | (Mar 4, 2026)
Inhouse | $5,000,000 | (Mar 3, 2026)